Ixico (LON:IXI) issued its quarterly earnings results on Tuesday. The company reported GBX (2) (($0.03)) EPS for the quarter, missing the Zacks’ consensus estimate of GBX (1.50) (($0.02)) by GBX (0.50) (($0.01)), Bloomberg Earnings reports.
Shares of IXI traded down GBX 1.50 ($0.02) on Thursday, reaching GBX 21.50 ($0.28). 760 shares of the company’s stock traded hands, compared to its average volume of 2,474. Ixico has a 52-week low of GBX 22.20 ($0.29) and a 52-week high of GBX 39.99 ($0.52).
WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/12/06/ixico-ixi-releases-earnings-results-misses-expectations-by-0-50-eps.html.
Ixico Company Profile
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer.
Featured Article: How to interpret a stock’s beta number
Receive News & Ratings for Ixico Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ixico and related companies with MarketBeat.com's FREE daily email newsletter.